Loading
4p pharma
  • About Us
    • Our Team
  • Pipeline
    • Inflammation
    • Cancer
    • Abuse deterrent formulations
  • Partnerships
    • Our Business Model
    • Working with VCs and investors
    • Working with biotech and pharma startups
    • Working with academics and TTOs
    • Our Partners
  • R&D Tools
    • Cancer
    • Inflammatory models
    • Infectious models
  • News
  • Contact Us
  • Search
  • Twitter
  • Linkedin
News
News & Events

4P Pharma on LinkedIn

4p-pharma linkedin

Follow the latest news in science, medicine and pharma on our LinkedIn page
www.linkedin.com/company/4p-pharma

 

 

10/20/2014/by admin
Tags: 4p-pharma, linked in, news, science
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share by Mail

About Us

4P Pharma develops flexible partnership with academics and industries on a co-risk co-share model. We translate ideas into products.


  • Terms of use

Sitemap

  • About Us
  • Pipeline
  • Our Business Model
  • Partnerships
  • R&D Tools
  • Contact Us

Latest Tweets

Tweets by @4P_Pharma

Contact us

Campus de l'Institut Pasteur de Lille 1 Rue du Professeur Calmette 59000 Lille, France
and
82, rue de Provence 75009 Paris, France
+33 9 50 72 97 68 contact@4p-pharma.com

Latest News

  • Attention-Deficit-Hyperactivity-Disorder-Pipeline-Drug-Development-Market-H2-20174P-Pharma an actor in ADHD pipeline drug development08/21/2017 - 2:14 PM
  • lih-logoConference talk at the Luxembourg Institute of Health07/06/2017 - 12:23 PM
  • Visuel_PSC24P-Pharma à la 2e édition du Paris-Saclay Connexion06/12/2017 - 12:08 PM
Followon TwitterSubscribeto RSS Feed
© Copyright - 4P-Pharma | Programming: Roy Eyal Studio | Design: Liora Schirer Studio
  • Twitter
  • Linkedin
  • About Us
  • Pipeline
  • Partnerships
  • R&D Tools
  • News
  • Contact Us
4P Pharma on Twitter 4p-pharma twitter logo 4p pharma 4P Pharma at BioFIT 2014
We are using cookies to improve user experience on our website. By using this website you consent to the use of cookies in accordance with this Cookie Notice.Ok
Scroll to top